Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Moonlake Immunotherapeutics (MLTX)
Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,012,395
  • Shares Outstanding, K 62,446
  • Annual Sales, $ 0 K
  • Annual Income, $ -49,970 K
  • 60-Month Beta 1.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.65
Trade MLTX with:

Options Overview Details

View History
  • Implied Volatility 100.44% ( -3.12%)
  • Historical Volatility 65.96%
  • IV Percentile 36%
  • IV Rank 34.87%
  • IV High 173.15% on 11/03/23
  • IV Low 61.50% on 11/14/23
  • Put/Call Vol Ratio 0.09
  • Today's Volume 3,470
  • Volume Avg (30-Day) 1,206
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 19,971
  • Open Int (30-Day) 18,797

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.21
  • Number of Estimates 7
  • High Estimate -0.15
  • Low Estimate -0.27
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +32.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.08 +2.46%
on 02/29/24
64.98 -25.76%
on 02/12/24
-9.93 (-17.07%)
since 01/29/24
3-Month
42.51 +13.48%
on 11/30/23
64.98 -25.76%
on 02/12/24
+5.95 (+14.07%)
since 11/29/23
52-Week
17.82 +170.71%
on 04/14/23
64.98 -25.76%
on 02/12/24
+29.05 (+151.38%)
since 02/28/23

Most Recent Stories

More News
Will this year's top performing stock ETFs stay hot in '24?

Even if there is a clear market rotation, these top performing ETFs will have an opportunity to secure gains and move on to be potential trophy winners in 2024.

ARKK : 51.25 (+0.18%)
FBCG.BZ : N/A (unch)
VCAR : 10.45 (+2.05%)
COIN : 203.56 (+1.37%)
ROKU : 63.18 (-0.83%)
META : 490.13 (+1.26%)
PLTR : 25.08 (+2.70%)
SHOP : 76.37 (+1.07%)
NVDA : 791.12 (+1.87%)
UBER : 79.50 (+2.28%)
ANF : 127.76 (+1.40%)
DKNG : 43.32 (+2.34%)
Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday

A competitor's clinical trial stumble may be benefiting MoonLake.

SLRN : 8.45 (-0.59%)
MLTX : 48.24 (-15.09%)
MarketBeat Week in Review – 6/26 - 6/30

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

NIO : 5.75 (+5.89%)
FROG : 44.79 (-0.02%)
MLTX : 48.24 (-15.09%)
MDB : 447.58 (+0.93%)
SHW : 332.03 (+0.71%)
GIS : 64.18 (-0.19%)
MULN : 7.12 (+0.14%)
AAPL : 180.75 (-0.37%)
GOOGL : 138.46 (+1.53%)
LCID : 3.30 (+2.17%)
KFY : 63.66 (+3.97%)
META : 490.13 (+1.26%)
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week

Positive mid-stage results fueled a spike in the biotech's shares this week.

MLTX : 48.24 (-15.09%)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 48.24 (-15.09%)
IMGN : 31.23 (unch)
Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today

The heavily bullish sentiment on the company only grew on the second trading day of the week.

BCS : 8.50 (-1.51%)
MLTX : 48.24 (-15.09%)
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday

The company reported positive phase 2 clinical trial results.

MLTX : 48.24 (-15.09%)
MoonLake Immunotherapeutics (NASDAQ: MLTX) Announces Breakthrough Results for Sonelokimab in Phase 2 Trial

MoonLake Immunotherapeutics (NASDAQ: MLTX) has made significant strides with the successful outcome of their Phase 2 MIRA trial for sonelokimab,

MLTX : 48.24 (-15.09%)
Lucid Stock Moved Into the Fast Lane, but This Nasdaq Biotech Was Monday's Big Winner

Markets looked poised to start the new week flat.

COMP : 3.95 (+3.13%)
$NASX : 16,091.92 (+0.90%)
LCID : 3.30 (+2.17%)
MLTX : 48.24 (-15.09%)
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data, Powell Speech

September S&P 500 futures (ESU23) are down -0.12%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.22% this morning as market participants looked ahead to the release of the Fed’s favorite...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 201.88 (-0.08%)
NVDA : 791.12 (+1.87%)
JD : 22.62 (-0.83%)
PDD : 124.54 (-0.38%)
KMX : 79.00 (+2.99%)
DBK.D.DX : 12.516 (+1.05%)
AML.LN : 175.309 (+1.45%)
MLTX : 48.24 (-15.09%)
ETNB : 11.47 (-2.47%)
GOOGL : 138.46 (+1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 65.30
2nd Resistance Point 61.43
1st Resistance Point 54.83
Last Price 48.24
1st Support Level 44.36
2nd Support Level 40.49
3rd Support Level 33.89

See More

52-Week High 64.98
Last Price 48.24
Fibonacci 61.8% 46.96
Fibonacci 50% 41.40
Fibonacci 38.2% 35.84
52-Week Low 17.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar